{"id":"W4395076878","doi":"10.1093/rheumatology/keae163.206","title":"P167 Bimekizumab achieved sustained improvements in efficacy outcomes in patients with axial spondyloarthritis, regardless of prior tumour necrosis factor inhibitor treatment: week 52 pooled results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2","year":2024,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Axial spondyloarthritis; Internal medicine; Tumor necrosis factor alpha; Tumor necrosis factor α; Oncology; Ankylosing spondylitis; Sacroiliitis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004470775,0.000901857,0.002988126,0.0004517729,0.0002638414,0.001379252,0.0004707151,0.0008317956,0.003162252],"category_scores_gemma":[0.003687692,0.0004900369,0.005342486,0.0004509834,0.0003559464,0.0008139504,0.0005605448,0.001425029,0.0004601355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005153138,"about_ca_system_score_gemma":0.0009264691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006652618,"about_ca_topic_score_gemma":0.002144986,"domain_scores_codex":[0.9978729,0.001122954,0.0002920407,0.0003014292,0.0002296816,0.000180885],"domain_scores_gemma":[0.9979772,0.000664201,0.0007787697,0.0001648089,0.0002162425,0.0001987955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.794234,0.002687006,0.01709487,0.006928086,0.04606237,0.0001324555,0.0001677287,0.001461788,0.01520726,0.0001757482,0.003684349,0.1121644],"study_design_scores_gemma":[0.4425908,0.2651081,0.1920773,0.001414989,0.07776128,0.0007388326,0.0002296396,0.002407057,0.007230337,0.0006014777,0.009674085,0.0001661062],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9231153,0.06578562,0.001493564,0.0007433276,0.0003630388,0.001447347,0.002900058,0.0001385073,0.004013269],"genre_scores_gemma":[0.9915646,0.004662381,0.0006136382,0.0003696878,0.0001874526,0.0005540532,0.001124081,0.00001637885,0.0009076798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004470775,"threshold_uncertainty_score":0.02364403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01763009108632372,"score_gpt":0.2903626884384798,"score_spread":0.272732597352156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}